{"transactions":[{"id":1043401,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":75542,"kind":"person","name":"Karkus Ted William","position":1,"cik":"0001457896","reported_name":"Karkus Ted William","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & CHAIRMAN"}}],"security":"warrants","published_at":"2025-09-11T20:05:22.000Z","date":"2025-09-09","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Warrants issued upon increase in authorized shares being approved by shareholders. The Reporting Person loaned PRPH funds, with a contingency that a warrant to purchase 500,000 shares of the Issuer's common stock at an exercise price of $0.60 per share would be issued if and only if the company's shareholders approved an amendment to the Certificate of Incorporation increasing the authorized shares of common stock from 50,000,000 to 1,000,000,000. Shareholders approved the increase in the authorized shares on September 9, 2025. The Warrant is described in the Issuer's Current Report on Form 8-K/A filed June 26, 2025 (Item 1.01), which states the Warrant has a five-year term. The expiration date shown (09/09/2030) is a five-year term from the issuance date. The Warrant was issued as consideration in connection with a related-party loan agreement between the Issuer and the Reporting Person dated June 22, 2025. See Form 8-K/A filed June 26, 2025 for additional details."}],"balance_after":500000,"derivative":{"exercise_price":0.6,"expiration_date":"2030-09-09","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001641172-25-027126","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000164117225027126/ownership.xml","form_type":"4"}},{"id":1254199,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":82942,"kind":"person","name":"Hollenshead Stuart","position":1,"cik":"0002057407","reported_name":"Hollenshead Stuart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Option (right to buy)","published_at":"2025-02-21T22:15:08.000Z","date":"2025-02-17","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Stock option granted as an inducement award. The option vests over a three-year period, with 25% vesting on the date of grant and 25% vesting on each of the next three anniversaries thereafter, subject to the Reporting Person's continued service through each vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock option granted as an inducement award. The option vests over a three-year period, with 25% vesting on the date of grant and 25% vesting on each of the next three anniversaries thereafter, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":500000,"derivative":{"exercise_price":0.6,"expiration_date":"2032-02-17","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001493152-25-007918","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315225007918/ownership.xml","form_type":"4"}},{"id":1265400,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":83142,"kind":"person","name":"Hirsch Warren","position":1,"cik":"0001797074","reported_name":"Hirsch Warren","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2025-02-18T22:00:14.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options shall vest and become exercisable in four equal installments, with 25% of such award vesting and becoming exercisable on each of September 30, 2025, December 31, 2025, March 31, 2026 and June 30, 2026 provided the recipient continues to serve as a non-employee director of the Issuer on each such vesting date."}],"balance_after":100000,"derivative":{"exercise_price":0.6,"expiration_date":"2032-02-14","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001493152-25-007201","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315225007201/ownership.xml","form_type":"4"}},{"id":1265399,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":83141,"kind":"person","name":"GLECKEL LOUIS MD","position":1,"cik":"0001164762","reported_name":"GLECKEL LOUIS MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2025-02-18T22:00:13.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options shall vest and become exercisable in four equal installments, with 25% of such award vesting and becoming exercisable on each of September 30, 2025, December 31, 2025, March 31, 2026 and June 30, 2026 provided the recipient continues to serve as a non-employee director of the Issuer on each such vesting date."}],"balance_after":100000,"derivative":{"exercise_price":0.6,"expiration_date":"2032-02-14","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001493152-25-007199","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315225007199/ownership.xml","form_type":"4"}},{"id":1565343,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":75542,"kind":"person","name":"Karkus Ted William","position":1,"cik":"0001457896","reported_name":"Karkus Ted William","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO & CHAIRMAN"}}],"security":"Option (right to buy)","published_at":"2024-03-21T20:30:10.000Z","date":"2024-03-17","kind":"grant","planned":false,"acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This amended report on Form 4 is being filed to correct the information in Table II, Box 5 as the share amount was inadvertently reported under the wrong subheading in the original Form 4 filed on March 19, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options shall vest and become exercisable in four equal installments, with 25% of such award vesting and becoming exercisable on the grant date and the remainder vesting and becoming exercisable in equal annual installments on the first, second and third anniversaries of the grant date."}],"balance_after":400000,"derivative":{"exercise_price":6,"expiration_date":"2031-03-17","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001493152-24-010787","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315224010787/ownership.xml","form_type":"4/A","original_submission_date":"2024-03-19"}},{"id":1570877,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":88312,"kind":"person","name":"Latkin Jed","position":1,"cik":"0001554593","reported_name":"Latkin Jed","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2024-03-20T01:52:58.000Z","date":"2024-01-01","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests over a three year period, with 25% vesting on the date of grant and 25% vesting on each anniversary thereafter, subject to the Reporting Person's continued service through each vesting date"}],"balance_after":500000,"derivative":{"exercise_price":6,"expiration_date":"2031-01-01","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001493152-24-010575","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315224010575/ownership.xml","form_type":"4"}},{"id":1570876,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":83142,"kind":"person","name":"Hirsch Warren","position":1,"cik":"0001797074","reported_name":"Hirsch Warren","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2024-03-20T01:50:15.000Z","date":"2024-03-17","kind":"grant","planned":false,"acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options shall vest and become exercisable in four equal installments, with 25% of such award vesting and becoming exercisable on each of September 30, 2024, December 31, 2024, March 31, 2025 and June 30, 2025 provided the recipient continues to serve as a non-employee director of the Issuer on each such vesting date."}],"balance_after":70000,"derivative":{"exercise_price":6,"expiration_date":"2031-03-17","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001493152-24-010573","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315224010573/ownership.xml","form_type":"4"}},{"id":1570875,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":83141,"kind":"person","name":"GLECKEL LOUIS MD","position":1,"cik":"0001164762","reported_name":"GLECKEL LOUIS MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2024-03-20T01:49:45.000Z","date":"2024-03-17","kind":"grant","planned":false,"acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options shall vest and become exercisable in four equal installments, with 25% of such award vesting and becoming exercisable on each of September 30, 2024, December 31, 2024, March 31, 2025 and June 30, 2025 provided the recipient continues to serve as a non-employee director of the Issuer on each such vesting date."}],"balance_after":70000,"derivative":{"exercise_price":6,"expiration_date":"2031-03-17","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001493152-24-010572","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315224010572/ownership.xml","form_type":"4"}},{"id":1570874,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":92919,"kind":"person","name":"Barr Jason Michael","position":1,"cik":"0001645550","reported_name":"Barr Jason Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2024-03-20T01:49:03.000Z","date":"2024-03-17","kind":"grant","planned":false,"acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options shall vest and become exercisable in four equal installments, with 25% of such award vesting and becoming exercisable on each of September 30, 2024, December 31, 2024, March 31, 2025 and June 30, 2025 provided the recipient continues to serve as a non-employee director of the Issuer on each such vesting date."}],"balance_after":70000,"derivative":{"exercise_price":6,"expiration_date":"2031-03-17","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001493152-24-010571","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315224010571/ownership.xml","form_type":"4"}},{"id":1570873,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":75542,"kind":"person","name":"Karkus Ted William","position":1,"cik":"0001457896","reported_name":"Karkus Ted William","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO & CHAIRMAN"}}],"security":"Option (right to buy)","published_at":"2024-03-20T01:48:06.000Z","date":"2024-03-17","kind":"grant","planned":false,"acquired":false,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options shall vest and become exercisable in four equal installments, with 25% of such award vesting and becoming exercisable on the grant date and the remainder vesting and becoming exercisable in equal annual installments on the first, second and third anniversaries of the grant date."}],"balance_after":400000,"derivative":{"exercise_price":6,"expiration_date":"2031-03-17","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001493152-24-010570","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315224010570/ownership.xml","form_type":"4"}},{"id":1847220,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":83142,"kind":"person","name":"Hirsch Warren","position":1,"cik":"0001797074","reported_name":"Hirsch Warren","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2023-06-23T00:19:40.000Z","date":"2023-06-16","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The transaction reported in this row involves a grant by the Issuer to the Reporting Person of a stock option to purchase the Issuer's common stock, with such option vesting in four equal installments on September 30, 2023, December 31, 2023, March 31, 2024 and June 30, 2024, provided the recipient continues to serve as a non-employee director of the Issuer on each such vesting date, as detailed in a stock option award agreement by and between the Issuer and the Reporting Person, dated as of June 16, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This amended report on Form 4 is being filed to correct the Transaction Date and Expiration Date of the Option, which were inadvertently misreported in the original Form 4 filed on June 21, 2023."}],"balance_after":40000,"derivative":{"exercise_price":7.31,"expiration_date":"2030-06-15","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001493152-23-022165","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315223022165/ownership.xml","form_type":"4/A","original_submission_date":"2023-06-21"}},{"id":1847219,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":83141,"kind":"person","name":"GLECKEL LOUIS MD","position":1,"cik":"0001164762","reported_name":"GLECKEL LOUIS MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2023-06-23T00:17:33.000Z","date":"2023-06-16","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The transaction reported in this row involves a grant by the Issuer to the Reporting Person of a stock option to purchase the Issuer's common stock (the \"Option\"), with such option vesting in four equal installments on September 30, 2023, December 31, 2023, March 31, 2024 and June 30, 2024, provided the recipient continues to serve as a non-employee director of the Issuer on each such vesting date, as detailed in a stock option award agreement by and between the Issuer and the Reporting Person, dated as of June 16, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This amended report on Form 4 is being filed to correct the Transaction Date and Expiration Date of the Option, which were inadvertently misreported in the original Form 4 filed on June 21, 2023."}],"balance_after":40000,"derivative":{"exercise_price":7.31,"expiration_date":"2030-06-15","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001493152-23-022163","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315223022163/ownership.xml","form_type":"4/A","original_submission_date":"2023-06-21"}},{"id":1847218,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":92919,"kind":"person","name":"Barr Jason Michael","position":1,"cik":"0001645550","reported_name":"Barr Jason Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2023-06-23T00:12:19.000Z","date":"2023-06-16","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The transaction reported in this row involves a grant by the Issuer to the Reporting Person of a stock option to purchase the Issuer's common stock (the \"Option\"), with such option vesting in four equal installments on September 30, 2023, December 31, 2023, March 31, 2024 and June 30, 2024, provided the recipient continues to serve as a non-employee director of the Issuer on each such vesting date, as detailed in a stock option award agreement by and between the Issuer and the Reporting Person, dated as of June 16, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This amended report on Form 4 is being filed to correct the Transaction Date and Expiration Date of the Option, which were inadvertently misreported in the original Form 4 filed on June 21, 2023."}],"balance_after":40000,"derivative":{"exercise_price":7.31,"expiration_date":"2030-06-15","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001493152-23-022161","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315223022161/ownership.xml","form_type":"4/A","original_submission_date":"2023-06-21"}},{"id":1848317,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":83142,"kind":"person","name":"Hirsch Warren","position":1,"cik":"0001797074","reported_name":"Hirsch Warren","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2023-06-21T20:15:33.000Z","date":"2023-06-19","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The transaction reported in this row involves a grant by the Issuer to the Reporting Person of a stock option to purchase the Issuer's common stock, with such option vesting in four equal installments on September 30, 2023, December 31, 2023, March 31, 2024 and June 30, 2024, provided the recipient continues to serve as a non-employee director of the Issuer on each such vesting date, as detailed in a stock option award agreement by and between the Issuer and the Reporting Person, dated as of June 19, 2023."}],"balance_after":40000,"derivative":{"exercise_price":7.31,"expiration_date":"2023-06-18","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001493152-23-022009","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315223022009/ownership.xml","form_type":"4"}},{"id":1848316,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":92919,"kind":"person","name":"Barr Jason Michael","position":1,"cik":"0001645550","reported_name":"Barr Jason Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2023-06-21T20:15:30.000Z","date":"2023-06-19","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The transaction reported in this row involves a grant by the Issuer to the Reporting Person of a stock option to purchase the Issuer's common stock, with such option vesting in four equal installments on September 30, 2023, December 31, 2023, March 31, 2024 and June 30, 2024, provided the recipient continues to serve as a non-employee director of the Issuer on each such vesting date, as detailed in a stock option award agreement by and between the Issuer and the Reporting Person, dated as of June 19, 2023."}],"balance_after":40000,"derivative":{"exercise_price":7.31,"expiration_date":"2023-06-18","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001493152-23-022008","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315223022008/ownership.xml","form_type":"4"}},{"id":1848315,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":83141,"kind":"person","name":"GLECKEL LOUIS MD","position":1,"cik":"0001164762","reported_name":"GLECKEL LOUIS MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2023-06-21T20:15:26.000Z","date":"2023-06-19","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The transaction reported in this row involves a grant by the Issuer to the Reporting Person of a stock option to purchase the Issuer's common stock, with such option vesting in four equal installments on September 30, 2023, December 31, 2023, March 31, 2024 and June 30, 2024, provided the recipient continues to serve as a non-employee director of the Issuer on each such vesting date, as detailed in a stock option award agreement by and between the Issuer and the Reporting Person, dated as of June 19, 2023."}],"balance_after":40000,"derivative":{"exercise_price":7.31,"expiration_date":"2023-06-18","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001493152-23-022007","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315223022007/ownership.xml","form_type":"4"}},{"id":1924168,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":114626,"kind":"person","name":"Morse Robert A. Jr.","position":1,"cik":"0001960049","reported_name":"Morse Robert A. Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Option (right to buy)","published_at":"2023-04-06T20:20:35.000Z","date":"2023-04-04","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The transaction reported in this row involves a grant by the Issuer to the Reporting Person of options to purchase the Issuer's common stock that will vest in five equal annual installments beginning April 5, 2024, subject to the Reporting Person's continued employment with the Issuer on each vesting date."}],"balance_after":50000,"derivative":{"exercise_price":9,"expiration_date":"2031-04-03","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-23-011249","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315223011249/ownership.xml","form_type":"4"}},{"id":1925968,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":75542,"kind":"person","name":"Karkus Ted William","position":1,"cik":"0001457896","reported_name":"Karkus Ted William","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO & CHAIRMAN"}}],"security":"Common Stock, par value $0.005","published_at":"2023-04-05T20:38:48.000Z","date":"2023-04-05","kind":"gift","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Son"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction involved a gift of securities by the Reporting Person to his son, who shares the Reporting Person's household."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Reporting Person's son, who shares the Reporting Person's household."}],"balance_after":150000,"source":{"system":"sec-edgar","filing":"0001493152-23-011050","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315223011050/ownership.xml","form_type":"4"}},{"id":1925967,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":75542,"kind":"person","name":"Karkus Ted William","position":1,"cik":"0001457896","reported_name":"Karkus Ted William","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO & CHAIRMAN"}}],"security":"Common Stock, par value $0.005","published_at":"2023-04-05T20:38:48.000Z","date":"2023-04-05","kind":"gift","planned":false,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction involved a gift of securities by the Reporting Person to his son, who shares the Reporting Person's household."}],"balance_after":3433750,"source":{"system":"sec-edgar","filing":"0001493152-23-011050","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315223011050/ownership.xml","form_type":"4"}},{"id":1930540,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":75542,"kind":"person","name":"Karkus Ted William","position":1,"cik":"0001457896","reported_name":"Karkus Ted William","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO & CHAIRMAN"}}],"security":"Option (right to buy)","published_at":"2023-04-04T20:27:17.000Z","date":"2023-04-03","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The transaction reported in this row involves a grant by the Issuer to the Reporting Person of options to purchase the Issuer's common stock that will vest in five equal annual installments beginning April 3, 2024, subject to the Reporting Person's continued employment with the Issuer on each vesting date."}],"balance_after":500000,"derivative":{"exercise_price":9,"expiration_date":"2031-04-02","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001493152-23-010830","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315223010830/ownership.xml","form_type":"4"}},{"id":1930539,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":75542,"kind":"person","name":"Karkus Ted William","position":1,"cik":"0001457896","reported_name":"Karkus Ted William","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO & CHAIRMAN"}}],"security":"Common Stock, par value $0.005","published_at":"2023-04-04T20:27:17.000Z","date":"2023-04-03","kind":"gift","planned":false,"acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction involved a gift of securities by the Reporting Person to his son, who does not share the Reporting Person's household."}],"balance_after":3483750,"source":{"system":"sec-edgar","filing":"0001493152-23-010830","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315223010830/ownership.xml","form_type":"4"}},{"id":2037278,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":75542,"kind":"person","name":"Karkus Ted William","position":1,"cik":"0001457896","reported_name":"Karkus Ted William","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO & CHAIRMAN"}}],"security":"Option (right to buy)","published_at":"2023-02-02T21:33:15.000Z","date":"2023-02-01","kind":"exercise","acquired":false,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 1, 2023, the Reporting Person acquired net 231,663 shares of common stock upon the exercise of stock options to purchase 500,000 shares of common stock, less 268,337 shares of common stock withheld to cover the exercise price and applicable taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vested in 35 equal monthly installments of 63,888 shares on the 1st day of each month beginning on March 1, 2018 (the \"Initial Vesting Date\"), and one monthly installment of 63,920 shares on the 1st day of the 36th month following the Initial Vesting Date, as described in a stock option award agreement by and between the Issuer and the Reporting Person, dated as of February 19, 2018."}],"balance_after":0,"derivative":{"exercise_price":0.6,"expiration_date":"2023-02-22","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001493152-23-003428","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315223003428/ownership.xml","form_type":"4"}},{"id":2037277,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":75542,"kind":"person","name":"Karkus Ted William","position":1,"cik":"0001457896","reported_name":"Karkus Ted William","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO & CHAIRMAN"}}],"security":"Common Stock, par value $0.005","published_at":"2023-02-02T21:33:15.000Z","date":"2023-02-01","kind":"tax_withholding","acquired":false,"shares":268337,"price":8.18,"value":2194996.66,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 1, 2023, the Reporting Person acquired net 231,663 shares of common stock upon the exercise of stock options to purchase 500,000 shares of common stock, less 268,337 shares of common stock withheld to cover the exercise price and applicable taxes."}],"balance_after":3583750,"source":{"system":"sec-edgar","filing":"0001493152-23-003428","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315223003428/ownership.xml","form_type":"4"}},{"id":2037276,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":75542,"kind":"person","name":"Karkus Ted William","position":1,"cik":"0001457896","reported_name":"Karkus Ted William","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO & CHAIRMAN"}}],"security":"Common Stock, par value $0.005","published_at":"2023-02-02T21:33:15.000Z","date":"2023-02-01","kind":"exercise","acquired":true,"shares":500000,"price":0.6,"value":300000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 1, 2023, the Reporting Person acquired net 231,663 shares of common stock upon the exercise of stock options to purchase 500,000 shares of common stock, less 268,337 shares of common stock withheld to cover the exercise price and applicable taxes."}],"balance_after":3852087,"source":{"system":"sec-edgar","filing":"0001493152-23-003428","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315223003428/ownership.xml","form_type":"4"}},{"id":2054123,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":75542,"kind":"person","name":"Karkus Ted William","position":1,"cik":"0001457896","reported_name":"Karkus Ted William","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO & CHAIRMAN"}}],"security":"Option (right to buy)","published_at":"2023-01-17T21:37:46.000Z","date":"2023-01-13","kind":"exercise","acquired":false,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On January 13, 2023, the Reporting Person acquired net 280,769 shares of common stock upon the exercise of stock options to purchase 600,000 shares of common stock, less 319,231 shares of common stock withheld to cover the exercise price and applicable taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vested in 35 equal monthly installments of 63,888 shares on the 1st day of each month beginning on March 1, 2018 (the \"Initial Vesting Date\"), and one monthly installment of 63,920 shares on the 1st day of the 36th month following the Initial Vesting Date, as described in a stock option award agreement by and between the Issuer and the Reporting Person, dated as of February 19, 2018."}],"balance_after":500000,"derivative":{"exercise_price":0.6,"expiration_date":"2023-02-22","underlying":"Common Stock","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0001493152-23-001631","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315223001631/ownership.xml","form_type":"4"}},{"id":2054122,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":75542,"kind":"person","name":"Karkus Ted William","position":1,"cik":"0001457896","reported_name":"Karkus Ted William","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO & CHAIRMAN"}}],"security":"Common Stock, par value $0.005","published_at":"2023-01-17T21:37:46.000Z","date":"2023-01-13","kind":"tax_withholding","acquired":false,"shares":319231,"price":9.36,"value":2988002.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On January 13, 2023, the Reporting Person acquired net 280,769 shares of common stock upon the exercise of stock options to purchase 600,000 shares of common stock, less 319,231 shares of common stock withheld to cover the exercise price and applicable taxes."}],"balance_after":3352087,"source":{"system":"sec-edgar","filing":"0001493152-23-001631","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315223001631/ownership.xml","form_type":"4"}},{"id":2054121,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":75542,"kind":"person","name":"Karkus Ted William","position":1,"cik":"0001457896","reported_name":"Karkus Ted William","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO & CHAIRMAN"}}],"security":"Common Stock, par value $0.005","published_at":"2023-01-17T21:37:46.000Z","date":"2023-01-13","kind":"exercise","acquired":true,"shares":600000,"price":0.6,"value":360000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On January 13, 2023, the Reporting Person acquired net 280,769 shares of common stock upon the exercise of stock options to purchase 600,000 shares of common stock, less 319,231 shares of common stock withheld to cover the exercise price and applicable taxes."}],"balance_after":3671318,"source":{"system":"sec-edgar","filing":"0001493152-23-001631","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315223001631/ownership.xml","form_type":"4"}},{"id":2135912,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":75542,"kind":"person","name":"Karkus Ted William","position":1,"cik":"0001457896","reported_name":"Karkus Ted William","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO & CHAIRMAN"}}],"security":"Option (right to buy)","published_at":"2022-10-18T13:34:07.000Z","date":"2022-10-16","kind":"exercise","acquired":false,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 16, 2022, the Reporting Person acquired net 282,709 shares of common stock upon the exercise of stock options to purchase 600,000 shares of common stock, less 317,291 shares of common stock withheld to cover the exercise price and applicable taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vested in 35 equal monthly installments of 63,888 shares on the 1st day of each month beginning on March 1, 2018 (the \"Initial Vesting Date\"), and one monthly installment of 63,920 shares on the 1st day of the 36th month following the Initial Vesting Date, as described in a stock option award agreement by and between the Issuer and the Reporting Person, dated as of February 19, 2018."}],"balance_after":1100000,"derivative":{"exercise_price":0.6,"expiration_date":"2023-02-22","underlying":"Common Stock","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0001493152-22-028621","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315222028621/ownership.xml","form_type":"4"}},{"id":2135911,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":75542,"kind":"person","name":"Karkus Ted William","position":1,"cik":"0001457896","reported_name":"Karkus Ted William","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO & CHAIRMAN"}}],"security":"Common Stock, par value $0.005","published_at":"2022-10-18T13:34:07.000Z","date":"2022-10-16","kind":"tax_withholding","acquired":false,"shares":317291,"price":10.41,"value":3302999.31,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 16, 2022, the Reporting Person acquired net 282,709 shares of common stock upon the exercise of stock options to purchase 600,000 shares of common stock, less 317,291 shares of common stock withheld to cover the exercise price and applicable taxes."}],"balance_after":3071318,"source":{"system":"sec-edgar","filing":"0001493152-22-028621","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315222028621/ownership.xml","form_type":"4"}},{"id":2135910,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":75542,"kind":"person","name":"Karkus Ted William","position":1,"cik":"0001457896","reported_name":"Karkus Ted William","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO & CHAIRMAN"}}],"security":"Common Stock, par value $0.005","published_at":"2022-10-18T13:34:07.000Z","date":"2022-10-16","kind":"exercise","acquired":true,"shares":600000,"price":0.6,"value":360000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 16, 2022, the Reporting Person acquired net 282,709 shares of common stock upon the exercise of stock options to purchase 600,000 shares of common stock, less 317,291 shares of common stock withheld to cover the exercise price and applicable taxes."}],"balance_after":3388609,"source":{"system":"sec-edgar","filing":"0001493152-22-028621","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315222028621/ownership.xml","form_type":"4"}},{"id":2190114,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":75542,"kind":"person","name":"Karkus Ted William","position":1,"cik":"0001457896","reported_name":"Karkus Ted William","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO & CHAIRMAN"}}],"security":"Option (right to buy)","published_at":"2022-08-11T01:23:38.000Z","date":"2022-08-10","kind":"exercise","acquired":false,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 10, 2022, the Reporting Person acquired net 283,395 shares of common stock upon the exercise of stock options to purchase 600,000 shares of common stock, less 316,605 shares of common stock withheld to cover the exercise price and applicable taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vested in 35 equal monthly installments of 63,888 shares on the 1st day of each month beginning on March 1, 2018 (the \"Initial Vesting Date\"), and one monthly installment of 63,920 shares on the 1st day of the 36th month following the Initial Vesting Date, as described in a stock option award agreement by and between the Issuer and the Reporting Person, dated as of February 19, 2018."}],"balance_after":1700000,"derivative":{"exercise_price":0.6,"expiration_date":"2023-02-22","underlying":"Common Stock","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0001493152-22-021940","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315222021940/ownership.xml","form_type":"4"}},{"id":2190113,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":75542,"kind":"person","name":"Karkus Ted William","position":1,"cik":"0001457896","reported_name":"Karkus Ted William","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO & CHAIRMAN"}}],"security":"Common Stock, par value $0.005","published_at":"2022-08-11T01:23:38.000Z","date":"2022-08-10","kind":"tax_withholding","acquired":false,"shares":316605,"price":10.84,"value":3431998.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 10, 2022, the Reporting Person acquired net 283,395 shares of common stock upon the exercise of stock options to purchase 600,000 shares of common stock, less 316,605 shares of common stock withheld to cover the exercise price and applicable taxes."}],"balance_after":2788609,"source":{"system":"sec-edgar","filing":"0001493152-22-021940","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315222021940/ownership.xml","form_type":"4"}},{"id":2190112,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":75542,"kind":"person","name":"Karkus Ted William","position":1,"cik":"0001457896","reported_name":"Karkus Ted William","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO & CHAIRMAN"}}],"security":"Common Stock, par value $0.005","published_at":"2022-08-11T01:23:38.000Z","date":"2022-08-10","kind":"exercise","acquired":true,"shares":600000,"price":0.6,"value":360000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 10, 2022, the Reporting Person acquired net 283,395 shares of common stock upon the exercise of stock options to purchase 600,000 shares of common stock, less 316,605 shares of common stock withheld to cover the exercise price and applicable taxes."}],"balance_after":3105214,"source":{"system":"sec-edgar","filing":"0001493152-22-021940","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315222021940/ownership.xml","form_type":"4"}},{"id":2215850,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":92919,"kind":"person","name":"Barr Jason Michael","position":1,"cik":"0001645550","reported_name":"Barr Jason Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2022-07-05T23:55:08.000Z","date":"2022-07-01","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The transaction reported in this row involves a grant by the Issuer to the Reporting Person of a stock option to purchase the Issuer's common stock, with such option vesting in four equal quarterly installments over one year, with the first quarterly installment to vest on September 30, 2022 and each additional installment to vest quarterly thereafter, provided the recipient continues to serve as a non-employee director of the Issuer on each such vesting date, as detailed in a stock option award agreement by and between the Issuer and the Reporting Person, dated as of July 1, 2022."}],"balance_after":40000,"derivative":{"exercise_price":12.92,"expiration_date":"2029-07-01","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001493152-22-018605","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315222018605/ownership.xml","form_type":"4"}},{"id":2215849,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":83141,"kind":"person","name":"GLECKEL LOUIS MD","position":1,"cik":"0001164762","reported_name":"GLECKEL LOUIS MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2022-07-05T23:51:37.000Z","date":"2022-07-01","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The transaction reported in this row involves a grant by the Issuer to the Reporting Person of a stock option to purchase the Issuer's common stock, with such option vesting in four equal quarterly installments over one year, with the first quarterly installment to vest on September 30, 2022 and each additional installment to vest quarterly thereafter, provided the recipient continues to serve as a non-employee director of the Issuer on each such vesting date, as detailed in a stock option award agreement by and between the Issuer and the Reporting Person, dated as of July 1, 2022."}],"balance_after":40000,"derivative":{"exercise_price":12.92,"expiration_date":"2029-07-01","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001493152-22-018603","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315222018603/ownership.xml","form_type":"4"}},{"id":2215846,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":83142,"kind":"person","name":"Hirsch Warren","position":1,"cik":"0001797074","reported_name":"Hirsch Warren","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2022-07-05T23:45:01.000Z","date":"2022-07-01","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The transaction reported in this row involves a grant by the Issuer to the Reporting Person of a stock option to purchase the Issuer's common stock, with such option vesting in four equal quarterly installments over one year, with the first quarterly installment to vest on September 30, 2022 and each additional installment to vest quarterly thereafter, provided the recipient continues to serve as a non-employee director of the Issuer on each such vesting date, as detailed in a stock option award agreement by and between the Issuer and the Reporting Person, dated as of July 1, 2022."}],"balance_after":40000,"derivative":{"exercise_price":12.92,"expiration_date":"2029-07-01","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001493152-22-018601","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315222018601/ownership.xml","form_type":"4"}},{"id":2257378,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":75542,"kind":"person","name":"Karkus Ted William","position":1,"cik":"0001457896","reported_name":"Karkus Ted William","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO & CHAIRMAN"}}],"security":"Option (right to buy)","published_at":"2022-05-25T21:20:44.000Z","date":"2022-05-23","kind":"exercise","acquired":false,"shares":450000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 23, 2022, the Reporting Person acquired net 171,743 shares of common stock upon the exercise of stock options to purchase 450,000 shares of common stock, less 278,257 shares of common stock withheld to cover the exercise price and applicable taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vested in four equal annual installments beginning April 26, 2018, as detailed in a stock option award agreement by and between the Issuer and the Reporting Person, dated as of April 27, 2017."}],"balance_after":0,"derivative":{"exercise_price":2,"expiration_date":"2024-04-27","underlying":"Common Stock","underlying_shares":450000},"source":{"system":"sec-edgar","filing":"0001493152-22-015068","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315222015068/ownership.xml","form_type":"4"}},{"id":2257377,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":75542,"kind":"person","name":"Karkus Ted William","position":1,"cik":"0001457896","reported_name":"Karkus Ted William","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO & CHAIRMAN"}}],"security":"Common Stock, par value $0.005","published_at":"2022-05-25T21:20:44.000Z","date":"2022-05-23","kind":"tax_withholding","acquired":false,"shares":278257,"price":8.47,"value":2356836.79,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 23, 2022, the Reporting Person acquired net 171,743 shares of common stock upon the exercise of stock options to purchase 450,000 shares of common stock, less 278,257 shares of common stock withheld to cover the exercise price and applicable taxes."}],"balance_after":2505214,"source":{"system":"sec-edgar","filing":"0001493152-22-015068","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315222015068/ownership.xml","form_type":"4"}},{"id":2257376,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":75542,"kind":"person","name":"Karkus Ted William","position":1,"cik":"0001457896","reported_name":"Karkus Ted William","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO & CHAIRMAN"}}],"security":"Common Stock, par value $0.005","published_at":"2022-05-25T21:20:44.000Z","date":"2022-05-23","kind":"exercise","acquired":true,"shares":450000,"price":2,"value":900000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 23, 2022, the Reporting Person acquired net 171,743 shares of common stock upon the exercise of stock options to purchase 450,000 shares of common stock, less 278,257 shares of common stock withheld to cover the exercise price and applicable taxes."}],"balance_after":2783471,"source":{"system":"sec-edgar","filing":"0001493152-22-015068","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315222015068/ownership.xml","form_type":"4"}},{"id":2257375,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":126951,"kind":"person","name":"Brady Monica L.","position":1,"cik":"0001718729","reported_name":"Brady Monica L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Option (right to buy)","published_at":"2022-05-25T21:18:43.000Z","date":"2022-05-23","kind":"exercise","acquired":false,"shares":14250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 23, 2022, the Reporting Person acquired net 27,444 shares of common stock upon the exercise of stock options to purchase 39,250 shares of common stock, less 11,806 shares of common stock withheld to cover the exercise price and applicable taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options vest in four equal annual installments beginning December 4, 2019, as detailed in a stock option award agreement by and between the Issuer and the Reporting Person, dated as of December 4, 2018."}],"balance_after":35750,"derivative":{"exercise_price":3.18,"expiration_date":"2025-12-03","underlying":"Common Stock","underlying_shares":14250},"source":{"system":"sec-edgar","filing":"0001493152-22-015066","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315222015066/ownership.xml","form_type":"4"}},{"id":2257374,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":126951,"kind":"person","name":"Brady Monica L.","position":1,"cik":"0001718729","reported_name":"Brady Monica L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Option (right to buy)","published_at":"2022-05-25T21:18:43.000Z","date":"2022-05-23","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 23, 2022, the Reporting Person acquired net 27,444 shares of common stock upon the exercise of stock options to purchase 39,250 shares of common stock, less 11,806 shares of common stock withheld to cover the exercise price and applicable taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to this option were vested and exercisable as of September 26, 2017, the date of grant, and the remaining 75% of the shares vested in three annual installments beginning on September 26, 2018."}],"balance_after":0,"derivative":{"exercise_price":2.15,"expiration_date":"2024-09-26","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001493152-22-015066","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315222015066/ownership.xml","form_type":"4"}},{"id":2257373,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":126951,"kind":"person","name":"Brady Monica L.","position":1,"cik":"0001718729","reported_name":"Brady Monica L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock, par value $0.0005","published_at":"2022-05-25T21:18:43.000Z","date":"2022-05-23","kind":"tax_withholding","acquired":false,"shares":11806,"price":8.47,"value":99996.82,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 23, 2022, the Reporting Person acquired net 27,444 shares of common stock upon the exercise of stock options to purchase 39,250 shares of common stock, less 11,806 shares of common stock withheld to cover the exercise price and applicable taxes."}],"balance_after":34872,"source":{"system":"sec-edgar","filing":"0001493152-22-015066","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315222015066/ownership.xml","form_type":"4"}},{"id":2257372,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":126951,"kind":"person","name":"Brady Monica L.","position":1,"cik":"0001718729","reported_name":"Brady Monica L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock, par value $0.0005","published_at":"2022-05-25T21:18:43.000Z","date":"2022-05-23","kind":"exercise","acquired":true,"shares":14250,"price":3.18,"value":45315.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 23, 2022, the Reporting Person acquired net 27,444 shares of common stock upon the exercise of stock options to purchase 39,250 shares of common stock, less 11,806 shares of common stock withheld to cover the exercise price and applicable taxes."}],"balance_after":46678,"source":{"system":"sec-edgar","filing":"0001493152-22-015066","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315222015066/ownership.xml","form_type":"4"}},{"id":2257371,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":126951,"kind":"person","name":"Brady Monica L.","position":1,"cik":"0001718729","reported_name":"Brady Monica L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock, par value $0.0005","published_at":"2022-05-25T21:18:43.000Z","date":"2022-05-23","kind":"exercise","acquired":true,"shares":25000,"price":2.15,"value":53750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 23, 2022, the Reporting Person acquired net 27,444 shares of common stock upon the exercise of stock options to purchase 39,250 shares of common stock, less 11,806 shares of common stock withheld to cover the exercise price and applicable taxes."}],"balance_after":32428,"source":{"system":"sec-edgar","filing":"0001493152-22-015066","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315222015066/ownership.xml","form_type":"4"}},{"id":2299710,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":92919,"kind":"person","name":"Barr Jason Michael","position":1,"cik":"0001645550","reported_name":"Barr Jason Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0005","published_at":"2022-04-11T22:05:21.000Z","date":"2022-03-10","kind":"purchase","acquired":true,"shares":721,"price":6.48,"value":4672.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction reported herein was a purchase of Issuer common stock pursuant to an automatic broker-administered dividend reinvestment program."},{"field":"shares","element":"transactionShares","label":"F2","text":"The original Form 4 filed on March 16, 2022 mistakenly reported that the Reporting Person acquired 750 shares pursuant to an automatic broker-administered dividend reinvestment program."}],"balance_after":30962,"source":{"system":"sec-edgar","filing":"0001493152-22-009627","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315222009627/ownership.xml","form_type":"4/A","original_submission_date":"2022-03-16"}},{"id":2331845,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":92919,"kind":"person","name":"Barr Jason Michael","position":1,"cik":"0001645550","reported_name":"Barr Jason Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0005","published_at":"2022-03-16T23:17:09.000Z","date":"2022-03-10","kind":"purchase","acquired":true,"shares":750,"price":6.48,"value":4860.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction reported herein was a purchase of Issuer common stock pursuant to an automatic broker-administered dividend reinvestment program."}],"balance_after":30991,"source":{"system":"sec-edgar","filing":"0001493152-22-007040","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315222007040/ownership.xml","form_type":"4"}},{"id":2674646,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":83142,"kind":"person","name":"Hirsch Warren","position":1,"cik":"0001797074","reported_name":"Hirsch Warren","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2021-06-10T20:05:37.000Z","date":"2021-06-09","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The transaction reported in this row involves a grant by the Issuer to the Reporting Person of a stock option to purchase the Issuer's common stock, with one-quarter of such stock option vesting on June 30, 2021 and the remaining portion vesting pro rata in equal monthly installments beginning July 31, 2021 and on the last day of each month thereafter, as detailed in a stock option award agreement by and between the Issuer and the Reporting Person, dated as of June 9, 2021."}],"balance_after":50000,"derivative":{"exercise_price":5.28,"expiration_date":"2028-06-09","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-21-014021","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315221014021/ownership.xml","form_type":"4"}},{"id":2674645,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":92919,"kind":"person","name":"Barr Jason Michael","position":1,"cik":"0001645550","reported_name":"Barr Jason Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2021-06-10T20:05:35.000Z","date":"2021-06-09","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The transaction reported in this row involves a grant by the Issuer to the Reporting Person of a stock option to purchase the Issuer's common stock, with one-quarter of such stock option vesting on June 30, 2021 and the remaining portion vesting pro rata in equal monthly installments beginning July 31, 2021 and on the last day of each month thereafter, as detailed in a stock option award agreement by and between the Issuer and the Reporting Person, dated as of June 9, 2021."}],"balance_after":100000,"derivative":{"exercise_price":5.28,"expiration_date":"2028-06-09","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001493152-21-014019","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315221014019/ownership.xml","form_type":"4"}},{"id":2674644,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":83141,"kind":"person","name":"GLECKEL LOUIS MD","position":1,"cik":"0001164762","reported_name":"GLECKEL LOUIS MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2021-06-10T20:05:22.000Z","date":"2021-06-09","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The transaction reported in this row involves a grant by the Issuer to the Reporting Person of a stock option to purchase the Issuer's common stock, with one-quarter of such stock option vesting on June 30, 2021 and the remaining portion vesting pro rata in equal monthly installments beginning July 31, 2021 and on the last day of each month thereafter, as detailed in a stock option award agreement by and between the Issuer and the Reporting Person, dated as of June 9, 2021."}],"balance_after":100000,"derivative":{"exercise_price":5.28,"expiration_date":"2028-06-09","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001493152-21-014017","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315221014017/ownership.xml","form_type":"4"}},{"id":2674643,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":75542,"kind":"person","name":"Karkus Ted William","position":1,"cik":"0001457896","reported_name":"Karkus Ted William","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO & CHAIRMAN"}}],"security":"Common Stock, par value $0.005","published_at":"2021-06-10T20:01:44.000Z","date":"2021-06-03","kind":"purchase","acquired":true,"shares":33943,"price":5.065,"value":171921.295,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction reported herein was an inadvertent purchase of Issuer common stock pursuant to an automatic broker-administered dividend reinvestment program. The dividend reinvestment feature of the reporting person's brokerage account has since been removed."}],"balance_after":2333471,"source":{"system":"sec-edgar","filing":"0001493152-21-014015","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315221014015/ownership.xml","form_type":"4"}},{"id":2721804,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":75542,"kind":"person","name":"Karkus Ted William","position":1,"cik":"0001457896","reported_name":"Karkus Ted William","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO & CHAIRMAN"}}],"security":"Common Stock, par value $0.005","published_at":"2021-05-10T21:30:25.000Z","date":"2021-05-07","kind":"gift","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Son"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Includes 60,000 shares that the Reporting Person gifted to his older son, who does not share the Reporting Person's household, and 60,000 shares that the Reporting Person gifted to his younger son, who does share the Reporting Person's household."}],"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001493152-21-010909","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315221010909/ownership.xml","form_type":"4"}},{"id":2721803,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":75542,"kind":"person","name":"Karkus Ted William","position":1,"cik":"0001457896","reported_name":"Karkus Ted William","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO & CHAIRMAN"}}],"security":"Common Stock, par value $0.005","published_at":"2021-05-10T21:30:25.000Z","date":"2021-05-07","kind":"gift","acquired":false,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Includes 60,000 shares that the Reporting Person gifted to his older son, who does not share the Reporting Person's household, and 60,000 shares that the Reporting Person gifted to his younger son, who does share the Reporting Person's household."}],"balance_after":2299528,"source":{"system":"sec-edgar","filing":"0001493152-21-010909","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315221010909/ownership.xml","form_type":"4"}},{"id":3033726,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":83142,"kind":"person","name":"Hirsch Warren","position":1,"cik":"0001797074","reported_name":"Hirsch Warren","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2020-09-11T20:17:21.000Z","date":"2020-09-10","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The transaction reported in this row involves a grant by the Issuer to the Reporting Person of a stock option to purchase the Issuer's common stock, with one-quarter of such stock option vesting on September 30, 2020 and the remaining portion vesting pro rata in equal monthly installments beginning October 31, 2020 and on the last day of each month thereafter, as detailed in a stock option award agreement by and between the Issuer and the Reporting Person, dated as of September 10, 2020."}],"balance_after":50000,"derivative":{"exercise_price":2.83,"expiration_date":"2027-09-09","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-20-017638","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315220017638/ownership.xml","form_type":"4"}},{"id":3033725,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":83141,"kind":"person","name":"GLECKEL LOUIS MD","position":1,"cik":"0001164762","reported_name":"GLECKEL LOUIS MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2020-09-11T20:17:20.000Z","date":"2020-09-10","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The transaction reported in this row involves a grant by the Issuer to the Reporting Person of a stock option to purchase the Issuer's common stock, with one-quarter of such stock option vesting on September 30, 2020 and the remaining portion vesting pro rata in equal monthly installments beginning October 31, 2020 and on the last day of each month thereafter, as detailed in a stock option award agreement by and between the Issuer and the Reporting Person, dated as of September 10, 2020."}],"balance_after":100000,"derivative":{"exercise_price":2.83,"expiration_date":"2027-09-09","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001493152-20-017640","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315220017640/ownership.xml","form_type":"4"}},{"id":3033724,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":92919,"kind":"person","name":"Barr Jason Michael","position":1,"cik":"0001645550","reported_name":"Barr Jason Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2020-09-11T20:17:19.000Z","date":"2020-09-10","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The transaction reported in this row involves a grant by the Issuer to the Reporting Person of a stock option to purchase the Issuer's common stock, with one-quarter of such stock option vesting on September 30, 2020 and the remaining portion vesting pro rata in equal monthly installments beginning October 31, 2020 and on the last day of each month thereafter, as detailed in a stock option award agreement by and between the Issuer and the Reporting Person, dated as of September 10, 2020."}],"balance_after":50000,"derivative":{"exercise_price":2.83,"expiration_date":"2027-09-09","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-20-017639","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315220017639/ownership.xml","form_type":"4"}},{"id":3055119,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":126951,"kind":"person","name":"Brady Monica L.","position":1,"cik":"0001718729","reported_name":"Brady Monica L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option (right to buy)","published_at":"2020-08-18T20:30:25.000Z","date":"2020-08-16","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The transaction reported in this row involves a grant by the Issuer to the Reporting Person of options to purchase the Issuer's common stock that will vest in four equal annual installments beginning August 16, 2020, as detailed in a stock option award agreement by and between the Issuer and the Reporting Person, dated as of August 16, 2020."}],"balance_after":150000,"derivative":{"exercise_price":2.64,"expiration_date":"2027-08-16","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001493152-20-016204","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315220016204/ownership.xml","form_type":"4"}},{"id":3056488,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":75542,"kind":"person","name":"Karkus Ted William","position":1,"cik":"0001457896","reported_name":"Karkus Ted William","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO & CHAIRMAN"}}],"security":"Common Stock, par value $0.005","published_at":"2020-08-17T20:30:32.000Z","date":"2020-08-13","kind":"sale","acquired":false,"shares":50000,"price":2.75,"value":137500.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were sold in a private transaction to Louis Gleckel, a director of the Issuer, pursuant to the terms of a Stock Purchase Agreement."}],"balance_after":2419528,"source":{"system":"sec-edgar","filing":"0001493152-20-016100","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315220016100/ownership.xml","form_type":"4"}},{"id":3056485,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":83141,"kind":"person","name":"GLECKEL LOUIS MD","position":1,"cik":"0001164762","reported_name":"GLECKEL LOUIS MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0005","published_at":"2020-08-17T20:30:30.000Z","date":"2020-08-13","kind":"purchase","acquired":true,"shares":50000,"price":2.75,"value":137500.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were purchased in a private transaction from Ted Karkus, Chairman and Chief Executive Officer of the Issuer, pursuant to the terms of a Stock Purchase Agreement"}],"balance_after":273840,"source":{"system":"sec-edgar","filing":"0001493152-20-016097","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315220016097/ownership.xml","form_type":"4"}},{"id":3084595,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":75542,"kind":"person","name":"Karkus Ted William","position":1,"cik":"0001457896","reported_name":"Karkus Ted William","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO & CHAIRMAN"}}],"security":"Common Stock, par value $0.005","published_at":"2020-07-14T00:39:25.000Z","date":"2020-07-09","kind":"gift","acquired":true,"shares":28600,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Son"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an additional 11,400 shares held by the Reporting Person's son that were previously included in the Reporting Person's direct holdings."}],"balance_after":40000,"source":{"system":"sec-edgar","filing":"0001493152-20-013210","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315220013210/ownership.xml","form_type":"4"}},{"id":3084594,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":75542,"kind":"person","name":"Karkus Ted William","position":1,"cik":"0001457896","reported_name":"Karkus Ted William","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO & CHAIRMAN"}}],"security":"Common Stock, par value $0.005","published_at":"2020-07-14T00:39:25.000Z","date":"2020-07-09","kind":"gift","acquired":true,"shares":25550,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Son"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes an additional 14,450 shares held by the Reporting Person's son that were previously included in the Reporting Person's direct holdings."}],"balance_after":40000,"source":{"system":"sec-edgar","filing":"0001493152-20-013210","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315220013210/ownership.xml","form_type":"4"}},{"id":3084593,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":75542,"kind":"person","name":"Karkus Ted William","position":1,"cik":"0001457896","reported_name":"Karkus Ted William","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO & CHAIRMAN"}}],"security":"Common Stock, par value $0.005","published_at":"2020-07-14T00:39:25.000Z","date":"2020-07-09","kind":"gift","acquired":false,"shares":54150,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2469528,"source":{"system":"sec-edgar","filing":"0001493152-20-013210","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315220013210/ownership.xml","form_type":"4"}},{"id":3093793,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":83141,"kind":"person","name":"GLECKEL LOUIS MD","position":1,"cik":"0001164762","reported_name":"GLECKEL LOUIS MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0005","published_at":"2020-07-02T17:32:28.000Z","date":"2020-07-01","kind":"grant","acquired":true,"shares":7878,"price":1.43,"value":11265.54,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares of common stock were issued under the 2010 Directors' Equity Compensation Plan, as amended, pursuant to an election by the Reporting Person to receive shares of common stock of the Issuer in lieu of a cash payment for quarterly director fees."}],"balance_after":223840,"source":{"system":"sec-edgar","filing":"0001493152-20-012453","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315220012453/ownership.xml","form_type":"4"}},{"id":3093787,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":92919,"kind":"person","name":"Barr Jason Michael","position":1,"cik":"0001645550","reported_name":"Barr Jason Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0005","published_at":"2020-07-02T15:35:51.000Z","date":"2020-07-01","kind":"grant","acquired":true,"shares":4727,"price":1.43,"value":6759.61,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares of common stock were issued under the 2010 Directors' Equity Compensation Plan, as amended, pursuant to an election by the Reporting Person to receive shares of\ncommon stock of the Issuer in lieu of a cash payment for quarterly director fees."}],"balance_after":30241,"source":{"system":"sec-edgar","filing":"0001493152-20-012442","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315220012442/ownership.xml","form_type":"4"}},{"id":3187749,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":83141,"kind":"person","name":"GLECKEL LOUIS MD","position":1,"cik":"0001164762","reported_name":"GLECKEL LOUIS MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0005","published_at":"2020-04-02T21:50:28.000Z","date":"2020-04-01","kind":"grant","acquired":true,"shares":6068,"price":1.85,"value":11225.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares of common stock were issued under the 2010 Directors' Equity Compensation Plan, as amended, pursuant to an election by the Reporting Person to receive shares of common stock of the Issuer in lieu of a cash payment for quarterly director fees."}],"balance_after":215962,"source":{"system":"sec-edgar","filing":"0001493152-20-005725","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315220005725/ownership.xml","form_type":"4"}},{"id":3187748,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":92919,"kind":"person","name":"Barr Jason Michael","position":1,"cik":"0001645550","reported_name":"Barr Jason Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0005","published_at":"2020-04-02T21:47:59.000Z","date":"2020-04-01","kind":"grant","acquired":true,"shares":3641,"price":1.85,"value":6735.85,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares of common stock were issued under the 2010 Directors' Equity Compensation Plan, as amended, pursuant to an election by the Reporting Person to receive shares of common stock of the Issuer in lieu of a cash payment for quarterly director fees."}],"balance_after":25514,"source":{"system":"sec-edgar","filing":"0001493152-20-005723","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315220005723/ownership.xml","form_type":"4"}},{"id":3193589,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":83141,"kind":"person","name":"GLECKEL LOUIS MD","position":1,"cik":"0001164762","reported_name":"GLECKEL LOUIS MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0005","published_at":"2020-03-27T23:17:50.000Z","date":"2020-03-26","kind":"purchase","acquired":true,"shares":100000,"price":1.75,"value":175000.0,"ownership":{"direct":true},"balance_after":209894,"source":{"system":"sec-edgar","filing":"0001493152-20-004963","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315220004963/ownership.xml","form_type":"4"}},{"id":3193588,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":75542,"kind":"person","name":"Karkus Ted William","position":1,"cik":"0001457896","reported_name":"Karkus Ted William","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO & CHAIRMAN"}}],"security":"Common Stock, par value $0.005","published_at":"2020-03-27T23:15:42.000Z","date":"2020-03-26","kind":"sale","acquired":false,"shares":100000,"price":1.75,"value":175000.0,"ownership":{"direct":true},"balance_after":2549528,"source":{"system":"sec-edgar","filing":"0001493152-20-004961","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315220004961/ownership.xml","form_type":"4"}},{"id":3325025,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":92919,"kind":"person","name":"Barr Jason Michael","position":1,"cik":"0001645550","reported_name":"Barr Jason Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0005","published_at":"2020-01-04T02:07:05.000Z","date":"2020-01-01","kind":"grant","acquired":true,"shares":2782,"price":2.02,"value":5619.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were issued to the Reporting Person under the 2010 Directors' Equity Compensation Plan, as amended, in lieu of a cash payment for quarterly director fees."}],"balance_after":21873,"source":{"system":"sec-edgar","filing":"0001493152-20-000171","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315220000171/ownership.xml","form_type":"4"}},{"id":3325024,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":83141,"kind":"person","name":"GLECKEL LOUIS MD","position":1,"cik":"0001164762","reported_name":"GLECKEL LOUIS MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0005","published_at":"2020-01-04T02:05:44.000Z","date":"2020-01-01","kind":"grant","acquired":true,"shares":5564,"price":2.02,"value":11239.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares of common stock were issued under the 2010 Directors' Equity Compensation Plan, as amended, pursuant to an election by the Reporting Person to receive shares of common stock of the Issuer in lieu of a cash payment for quarterly director fees."}],"balance_after":109894,"source":{"system":"sec-edgar","filing":"0001493152-20-000170","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315220000170/ownership.xml","form_type":"4"}},{"id":3361835,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":126951,"kind":"person","name":"Brady Monica L.","position":1,"cik":"0001718729","reported_name":"Brady Monica L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option (right to buy)","published_at":"2019-11-22T21:05:40.000Z","date":"2019-11-20","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The transaction reported in this row involves a grant by the Issuer to the Reporting Person of options to purchase the Issuer's common stock that will vest in four equal annual installments beginning November 20, 2019, as detailed in a stock option award agreement by and between the Issuer and the Reporting Person, dated as of November 20, 2019."}],"balance_after":100000,"derivative":{"exercise_price":2.01,"expiration_date":"2026-11-19","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001493152-19-018255","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315219018255/ownership.xml","form_type":"4"}},{"id":3399605,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":83141,"kind":"person","name":"GLECKEL LOUIS MD","position":1,"cik":"0001164762","reported_name":"GLECKEL LOUIS MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0005","published_at":"2019-10-03T22:44:31.000Z","date":"2019-10-01","kind":"grant","acquired":true,"shares":5740,"price":1.96,"value":11250.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares of common stock were issued under the 2010 Directors' Equity Compensation Plan, as amended, pursuant to an election by the Reporting Person to receive shares of common stock of the Issuer in lieu of a cash payment for quarterly director fees."}],"balance_after":104330,"source":{"system":"sec-edgar","filing":"0001493152-19-015007","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315219015007/ownership.xml","form_type":"4"}},{"id":3399604,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":92919,"kind":"person","name":"Barr Jason Michael","position":1,"cik":"0001645550","reported_name":"Barr Jason Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0005","published_at":"2019-10-03T22:42:49.000Z","date":"2019-10-01","kind":"purchase","acquired":true,"shares":2870,"price":1.96,"value":5625.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were issued to the Reporting Person under the 2010 Directors' Equity Compensation Plan, as amended, in lieu of a cash payment for quarterly director fees."}],"balance_after":19091,"source":{"system":"sec-edgar","filing":"0001493152-19-015005","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315219015005/ownership.xml","form_type":"4"}},{"id":3436797,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":83141,"kind":"person","name":"GLECKEL LOUIS MD","position":1,"cik":"0001164762","reported_name":"GLECKEL LOUIS MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0005","published_at":"2019-08-16T20:00:21.000Z","date":"2019-07-01","kind":"grant","acquired":true,"shares":4727,"price":2.38,"value":11250.26,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares of common stock were issued pursuant to the terms of the 2010 Directors' Equity Compensation Plan, as amended, for director fees payable to non-employee directors."}],"balance_after":98590,"source":{"system":"sec-edgar","filing":"0001493152-19-012854","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315219012854/ownership.xml","form_type":"4"}},{"id":3436796,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":92919,"kind":"person","name":"Barr Jason Michael","position":1,"cik":"0001645550","reported_name":"Barr Jason Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0005","published_at":"2019-08-16T20:00:20.000Z","date":"2019-08-15","kind":"purchase","acquired":true,"shares":2500,"price":2.05,"value":5125.0,"ownership":{"direct":true},"balance_after":16221,"source":{"system":"sec-edgar","filing":"0001493152-19-012853","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315219012853/ownership.xml","form_type":"4"}},{"id":3436795,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":92919,"kind":"person","name":"Barr Jason Michael","position":1,"cik":"0001645550","reported_name":"Barr Jason Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0005","published_at":"2019-08-16T20:00:20.000Z","date":"2019-08-14","kind":"purchase","acquired":true,"shares":6000,"price":2.05,"value":12300.0,"ownership":{"direct":true},"balance_after":13721,"source":{"system":"sec-edgar","filing":"0001493152-19-012853","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315219012853/ownership.xml","form_type":"4"}},{"id":3563349,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":83141,"kind":"person","name":"GLECKEL LOUIS MD","position":1,"cik":"0001164762","reported_name":"GLECKEL LOUIS MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0005","published_at":"2019-04-04T22:07:03.000Z","date":"2019-04-03","kind":"grant","acquired":true,"shares":3571,"price":3.15,"value":11248.65,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares of common stock were issued pursuant to the terms of the 2010 Directors' Equity Compensation Plan, as amended, for director fees payable to non-employee directors."}],"balance_after":93863,"source":{"system":"sec-edgar","filing":"0001493152-19-004917","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315219004917/ownership.xml","form_type":"4"}},{"id":3695865,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":83141,"kind":"person","name":"GLECKEL LOUIS MD","position":1,"cik":"0001164762","reported_name":"GLECKEL LOUIS MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0005","published_at":"2019-01-16T00:40:56.000Z","date":"2019-01-02","kind":"grant","acquired":true,"shares":3583,"price":3.14,"value":11250.62,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares of common stock were issued pursuant to the terms of the 2010 Directors' Equity Compensation Plan, as amended, for director fees payable to non-employee directors."}],"balance_after":90292,"source":{"system":"sec-edgar","filing":"0001493152-19-000674","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315219000674/ownership.xml","form_type":"4"}},{"id":3729999,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":126951,"kind":"person","name":"Brady Monica L.","position":1,"cik":"0001718729","reported_name":"Brady Monica L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Option (right to buy)","published_at":"2018-12-18T00:15:19.000Z","date":"2018-12-04","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The transaction reported in this row involves a grant by the Issuer to the Reporting Person of options to purchase the Issuer's common stock that will vest in four equal annual installments beginning December 04, 2019, as detailed in a stock option award agreement by and between the Issuer and the Reporting Person, dated as of December 04, 2018."}],"balance_after":50000,"derivative":{"exercise_price":3.18,"expiration_date":"2025-12-03","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-18-017621","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315218017621/ownership.xml","form_type":"4"}},{"id":3803173,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":83141,"kind":"person","name":"GLECKEL LOUIS MD","position":1,"cik":"0001164762","reported_name":"GLECKEL LOUIS MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0005","published_at":"2018-10-02T21:20:05.000Z","date":"2018-10-01","kind":"grant","acquired":true,"shares":3737,"price":3.01,"value":11248.37,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares of common stock were issued pursuant to the terms of the 2010 Directors' Equity Compensation Plan, as amended, for quarterly director fees payable to non-employee directors."}],"balance_after":86709,"source":{"system":"sec-edgar","filing":"0001493152-18-014009","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315218014009/ownership.xml","form_type":"4"}},{"id":3803172,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":163293,"kind":"person","name":"Burnett Mark A.","position":1,"cik":"0001459576","reported_name":"Burnett Mark A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0005","published_at":"2018-10-02T21:19:41.000Z","date":"2018-10-01","kind":"grant","acquired":true,"shares":3737,"price":3.01,"value":11248.37,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares of common stock were issued pursuant to the terms of the 2010 Directors' Equity Compensation Plan, as amended, for quarterly director fees payable to non-employee directors."}],"balance_after":318282,"source":{"system":"sec-edgar","filing":"0001493152-18-014008","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315218014008/ownership.xml","form_type":"4"}},{"id":3863142,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":83141,"kind":"person","name":"GLECKEL LOUIS MD","position":1,"cik":"0001164762","reported_name":"GLECKEL LOUIS MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0005","published_at":"2018-07-23T14:09:33.000Z","date":"2018-07-19","kind":"grant","acquired":true,"shares":3737,"price":3.01,"value":11248.37,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares of common stock were issued pursuant to the terms of the 2010 Directors' Equity Compensation Plan, as amended, for quarterly director fees payable to non-employee directors."}],"balance_after":82972,"source":{"system":"sec-edgar","filing":"0001493152-18-010342","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315218010342/ownership.xml","form_type":"4"}},{"id":3863141,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":163293,"kind":"person","name":"Burnett Mark A.","position":1,"cik":"0001459576","reported_name":"Burnett Mark A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0005","published_at":"2018-07-23T14:08:06.000Z","date":"2018-07-19","kind":"grant","acquired":true,"shares":3737,"price":3.01,"value":11248.37,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares of common stock were issued pursuant to the terms of the 2010 Directors' Equity Compensation Plan, as amended, for quarterly director fees payable to non-employee directors."}],"balance_after":314545,"source":{"system":"sec-edgar","filing":"0001493152-18-010341","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315218010341/ownership.xml","form_type":"4"}},{"id":3929373,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":75542,"kind":"person","name":"Karkus Ted William","position":1,"cik":"0001457896","reported_name":"Karkus Ted William","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO & CHAIRMAN"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-05-17T16:40:20.000Z","date":"2018-05-15","kind":"exercise","acquired":false,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"There employee stock options vested in an annual installment of 150,000 shares on April 26, 2018."}],"balance_after":450000,"derivative":{"exercise_price":2,"expiration_date":"2024-04-27","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001493152-18-007358","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315218007358/form4.xml","form_type":"4"}},{"id":3929372,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":75542,"kind":"person","name":"Karkus Ted William","position":1,"cik":"0001457896","reported_name":"Karkus Ted William","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO & CHAIRMAN"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-05-17T16:40:20.000Z","date":"2018-05-15","kind":"exercise","acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These employee stock options vested in annual installments of 50,000 and 50,000 shares on December 19, 2014 and 2015, respectively."}],"balance_after":0,"derivative":{"exercise_price":1.65,"expiration_date":"2019-12-18","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001493152-18-007358","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315218007358/form4.xml","form_type":"4"}},{"id":3929371,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":75542,"kind":"person","name":"Karkus Ted William","position":1,"cik":"0001457896","reported_name":"Karkus Ted William","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO & CHAIRMAN"}}],"security":"Common Stock, par value $0.005","published_at":"2018-05-17T16:40:20.000Z","date":"2018-05-15","kind":"tax_withholding","acquired":false,"shares":55046,"price":5.45,"value":300000.7,"ownership":{"direct":true},"balance_after":2649528,"source":{"system":"sec-edgar","filing":"0001493152-18-007358","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315218007358/form4.xml","form_type":"4"}},{"id":3929370,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":75542,"kind":"person","name":"Karkus Ted William","position":1,"cik":"0001457896","reported_name":"Karkus Ted William","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO & CHAIRMAN"}}],"security":"Common Stock, par value $0.005","published_at":"2018-05-17T16:40:20.000Z","date":"2018-05-15","kind":"exercise","acquired":true,"shares":150000,"price":2,"value":300000.0,"ownership":{"direct":true},"balance_after":2704574,"source":{"system":"sec-edgar","filing":"0001493152-18-007358","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315218007358/form4.xml","form_type":"4"}},{"id":3929369,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":75542,"kind":"person","name":"Karkus Ted William","position":1,"cik":"0001457896","reported_name":"Karkus Ted William","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO & CHAIRMAN"}}],"security":"Common Stock, par value $0.005","published_at":"2018-05-17T16:40:20.000Z","date":"2018-05-15","kind":"tax_withholding","acquired":false,"shares":30275,"price":5.45,"value":164998.75,"ownership":{"direct":true},"balance_after":2554574,"source":{"system":"sec-edgar","filing":"0001493152-18-007358","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315218007358/form4.xml","form_type":"4"}},{"id":3929368,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":75542,"kind":"person","name":"Karkus Ted William","position":1,"cik":"0001457896","reported_name":"Karkus Ted William","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO & CHAIRMAN"}}],"security":"Common Stock, par value $0.005","published_at":"2018-05-17T16:40:20.000Z","date":"2018-05-15","kind":"exercise","acquired":true,"shares":100000,"price":1.65,"value":165000.0,"ownership":{"direct":true},"balance_after":2584849,"source":{"system":"sec-edgar","filing":"0001493152-18-007358","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315218007358/form4.xml","form_type":"4"}},{"id":4035297,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":75542,"kind":"person","name":"Karkus Ted William","position":1,"cik":"0001457896","reported_name":"Karkus Ted William","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO & Chairman"}}],"security":"Option (right to buy)","published_at":"2018-02-26T21:23:50.000Z","date":"2018-02-23","kind":"grant","acquired":true,"shares":2300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The transaction reported in this row involves a grant by the Issuer to the Reporting Person of options to purchase 2,300,000 shares of the Issuer's common stock that will vest and be exercisable in 35 equal monthly installments of 63,888 shares on the 1st day of each month beginning on March 1, 2018 (the \"Initial Vesting Date\"), and one monthly installment of 63,920 shares on the 1st day of the 36th month following the Initial Vesting Date, subject to Mr. Karkus' continued employment with the Company, and subject to accelerated vesting in the event Mr. Karkus' employment is terminated for any reason other than by the Company for cause or by Mr. Karkus without good reason. The stock option may not be exercised unless and until the requisite stockholder approval is attained."}],"balance_after":2300000,"derivative":{"exercise_price":3,"expiration_date":"2023-02-22","underlying":"Common Stock","underlying_shares":2300000},"source":{"system":"sec-edgar","filing":"0001493152-18-002597","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315218002597/form4.xml","form_type":"4"}},{"id":4122007,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":75542,"kind":"person","name":"Karkus Ted William","position":1,"cik":"0001457896","reported_name":"Karkus Ted William","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO & CHAIRMAN"}}],"security":"Common Stock, par value $0.005","published_at":"2017-12-26T20:02:37.000Z","date":"2017-12-21","kind":"sale","acquired":false,"shares":424789,"price":2.3,"value":977014.7,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares were sold to the Issuer through the tender offer by the Issuer for 1,700,000 shares of its common stock."}],"balance_after":2484849,"source":{"system":"sec-edgar","filing":"0001493152-17-015051","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315217015051/form4.xml","form_type":"4"}},{"id":4129349,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":75542,"kind":"person","name":"Karkus Ted William","position":1,"cik":"0001457896","reported_name":"Karkus Ted William","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO & CHAIRMAN"}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-12-18T21:00:25.000Z","date":"2017-12-14","kind":"exercise","acquired":false,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These employee stock options vested in annual installments of 100,000, 100,000, 100,000 and 300,000 shares on December 14, 2011, 2012, 2013 and 2014, respectively."}],"balance_after":0,"derivative":{"exercise_price":1,"expiration_date":"2017-12-14","underlying":"Common Stock","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0001493152-17-014721","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315217014721/form4.xml","form_type":"4"}},{"id":4129348,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":75542,"kind":"person","name":"Karkus Ted William","position":1,"cik":"0001457896","reported_name":"Karkus Ted William","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO & CHAIRMAN"}}],"security":"Common Stock, par value $0.005","published_at":"2017-12-18T21:00:25.000Z","date":"2017-12-14","kind":"exercise","acquired":true,"shares":600000,"price":1,"value":600000.0,"ownership":{"direct":true},"balance_after":2909638,"source":{"system":"sec-edgar","filing":"0001493152-17-014721","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315217014721/form4.xml","form_type":"4"}},{"id":4198403,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":46438,"kind":"person","name":"Leonard Braden Michael","position":1,"cik":"0001373603","reported_name":"Leonard Braden Michael","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-10-02T19:04:37.000Z","date":"2017-09-29","kind":"sale","acquired":false,"shares":1695305,"price":2.3,"value":3899201.5,"ownership":{"direct":false,"nature":"Holding of BML Investment Partners, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"1. These shares were sold to the Issuer through the tender offer by the Issuer for 4,000,000 shares of its common stock."},{"field":"shares","element":"transactionShares","label":"F1","text":"1. These shares were sold to the Issuer through the tender offer by the Issuer for 4,000,000 shares of its common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"BML Capital Management, LLC (\"BML Capital\") serves as the general partner of BML Investment Partners, L.P., a Delaware limited partnership (the \"Fund\"), which is the direct owner of the subject shares. Mr. Leonard is the managing member of BML Capital, and exercises investment and voting control over the subject shares. Accordingly, shares owned directly by the Fund may be regarded as being beneficially owned by Mr. Leonard. Notwithstanding, Mr. Leonard disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein."}],"balance_after":627322,"source":{"system":"sec-edgar","filing":"0001140361-17-037087","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000114036117037087/doc1.xml","form_type":"4"}},{"id":4198402,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":92919,"kind":"person","name":"Barr Jason Michael","position":1,"cik":"0001645550","reported_name":"Barr Jason Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.005","published_at":"2017-10-02T16:56:13.000Z","date":"2017-09-29","kind":"sale","acquired":false,"shares":4379,"price":2.3,"value":10071.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were sold to the Issuer through the tender offer by the Issuer for 4,000,000 shares of its common stock."}],"balance_after":7721,"source":{"system":"sec-edgar","filing":"0001493152-17-011128","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315217011128/form4.xml","form_type":"4"}},{"id":4198398,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":172845,"kind":"person","name":"CUDDIHY ROBERT V JR","position":1,"cik":"0001142043","reported_name":"CUDDIHY ROBERT V JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, par value $0.005","published_at":"2017-10-02T16:54:25.000Z","date":"2017-09-29","kind":"sale","acquired":false,"shares":358621,"price":2.3,"value":824828.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were sold to the Issuer through the tender offer by the Issuer for 4,000,000 shares of its common stock."}],"balance_after":132703,"source":{"system":"sec-edgar","filing":"0001493152-17-011127","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315217011127/form4.xml","form_type":"4"}},{"id":4198397,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":75542,"kind":"person","name":"Karkus Ted William","position":1,"cik":"0001457896","reported_name":"Karkus Ted William","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO & CHAIRMAN"}}],"security":"Common Stock, par value $0.005","published_at":"2017-10-02T16:53:21.000Z","date":"2017-09-29","kind":"sale","acquired":false,"shares":364950,"price":2.3,"value":839385.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were sold to the Issuer through the tender offer by the Issuer for 4,000,000 shares of its common stock."}],"balance_after":2309638,"source":{"system":"sec-edgar","filing":"0001493152-17-011126","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315217011126/form4.xml","form_type":"4"}},{"id":4208803,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":172845,"kind":"person","name":"CUDDIHY ROBERT V JR","position":1,"cik":"0001142043","reported_name":"CUDDIHY ROBERT V JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-09-15T20:40:38.000Z","date":"2017-09-14","kind":"exercise","acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":1.39,"exercise_date":"2014-12-20","expiration_date":"2021-12-18","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001493152-17-010672","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315217010672/form4.xml","form_type":"4"}},{"id":4208802,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":172845,"kind":"person","name":"CUDDIHY ROBERT V JR","position":1,"cik":"0001142043","reported_name":"CUDDIHY ROBERT V JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-09-15T20:40:38.000Z","date":"2017-09-14","kind":"exercise","acquired":false,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":1.65,"exercise_date":"2014-12-19","expiration_date":"2019-12-18","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001493152-17-010672","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315217010672/form4.xml","form_type":"4"}},{"id":4208801,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":172845,"kind":"person","name":"CUDDIHY ROBERT V JR","position":1,"cik":"0001142043","reported_name":"CUDDIHY ROBERT V JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-09-15T20:40:38.000Z","date":"2017-09-14","kind":"exercise","acquired":false,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":1,"exercise_date":"2014-12-14","expiration_date":"2017-12-15","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001493152-17-010672","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315217010672/form4.xml","form_type":"4"}},{"id":4208800,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":172845,"kind":"person","name":"CUDDIHY ROBERT V JR","position":1,"cik":"0001142043","reported_name":"CUDDIHY ROBERT V JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, par value $0.005","published_at":"2017-09-15T20:40:38.000Z","date":"2017-09-14","kind":"exercise","acquired":true,"shares":40000,"price":1.39,"value":55600.0,"ownership":{"direct":true},"balance_after":491324,"source":{"system":"sec-edgar","filing":"0001493152-17-010672","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315217010672/form4.xml","form_type":"4"}}],"next_cursor":"2017-09-15T20:40:38.000000Z,4208800"}